Publicacions en què col·labora amb Cecilia M. Egoavil Rojas (15)

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

  2. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia

    PLoS ONE, Vol. 12, Núm. 9

  3. Prevalencia del síndrome de Lynch en pacientes con cáncer de endometrio no seleccionado

    Prevalencia del síndrome de Lynch en pacientes con cáncer de endometrio no seleccionado

2015

  1. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer

    Journal of Medical Genetics, Vol. 52, Núm. 7, pp. 498-502

2014

  1. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

    Human Molecular Genetics, Vol. 23, Núm. 13, pp. 3506-3512

  2. Prevalence and characteristics of mutyh-associated polyposis in patients with multiple adenomatous and serrated polyps

    Clinical Cancer Research, Vol. 20, Núm. 5, pp. 1158-1168

2013

  1. Clinical subtypes and molecular characteristics of serrated polyposis syndrome

    Clinical Gastroenterology and Hepatology, Vol. 11, Núm. 6, pp. 705-711

  2. Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

    Gut, Vol. 61, Núm. 6, pp. 865-872

  2. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer

    PLoS ONE, Vol. 7, Núm. 1

2011

  1. Clinically important molecular features of Peruvian colorectal tumours: High prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations

    Pathology, Vol. 43, Núm. 3, pp. 228-233

  2. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome

    BMC Medical Genetics, Vol. 12

2010

  1. EPCAM germ line deletions as causes of lynch syndrome in Spanish patients

    Journal of Molecular Diagnostics, Vol. 12, Núm. 6, pp. 765-770

  2. Germline allele-specific expression of TGFBR1 as a susceptibility factor for sporadic colorectal cancer

    EJC SUPPLEMENTS